Sentinel lymph node biopsy in cN0 squamous cell carcinoma of the lip: A retrospective study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 26514547.
- Also identified by DOI 10.1002/hed.24230.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to assess the use of sentinel lymph node biopsy (SLNB) in clinically lymph node-negative (cN0) squamous cell carcinoma (SCC) of the lip deemed high risk for occult nodal metastasis. Twenty-six patients with cT1 to T2 cN0 with SCC of the lip underwent SLNB at a tertiary referral center between January 2001 and March 2012. Initial staging methods were clinical examination only (65.4%), ultrasound (23.1%), or CT (11.5%). Operations were performed with the patients under local anesthesia with sedation (50%) or general anesthesia (50%). The mean follow-up time was 53 months. Three patients (11.5%) had a positive sentinel node and were upstaged. One SLNB-related complication was observed. Regional recurrence occurred in 2 patients (7.7%). The relationship between regional status and both tumor diameter and tumor thickness was statistically significant (p < .05). SLNB can be a viable staging technique in SCC of the lip. Tumor diameter of ≥ 20 mm and increasing tumor thickness seem to delineate higher risk for regional disease in our study. © 2015 Wiley Periodicals, Inc. Head Neck 38: E1375-E1380, 2016.
Medical subject headings
- Carcinoma, Squamous Cell
- Lip Neoplasms
- Sentinel Lymph Node Biopsy